Thanos Badekas, MD

• Director of Orthopedic Foot and Ankle Surgery
• Athineon Hospital
• Director of Department of Orthopaedics, Police Health Division
• Past President, Hellenic Foot and Ankle Society
• Athens, Greece

Treat ment consists of a diet restricted in plant sterols and cholesterol doctor for erectile dysfunction in bangalore avana 200 mg with mastercard, and the use of ezetimibe erectile dysfunction age statistics discount avana 200 mg buy on line. In many subjects with lipemia or with mild hypercholesterolemia erectile dysfunction pills otc purchase discount avana online, compliance with diet is sufficient to control lipoprotein levels erectile dysfunction 17 purchase genuine avana. The neurological mani festations of Niemann-Pick disease type C are mitigated by inhibi tors of glycosphingolipid synthesis impotence prozac cheap avana online. In the acute management of mixed lipemia with impending pan creatitis, elimination of dietary fat leads to a rapid decrease in triglycerides. The cholesterol-lowering effect of a significant reduction in total fat is well known. It has also been shown that a 10% to 1 5% fall in cholesterol is achieved when individuals who have been consuming a typical North American diet restrict their intake of saturated fats to 8% of total calories. Therefore, the total caloric content of the diet is of greater importance than its specific composition in treating endog enous hyperlipemia. On the other hand, many patients with hypertriglyceridemia-except most with chylo micronemia syndrome-are obese. Some individuals with familial hypertriglyceridemia are particularly sensitive to the effects of alcohol, and abstinence may normalize their triglycer ides. Occasionally, chronic alcohol intake may also be associated with hypercholesterolemia. Increased cholesterol synthesis and decreased conversion to bile acids have been observed. When a high-carbohydrate diet is consumed, hypertriglyceridemia often develops within 48 to 72 hours, and levels of triglycerides rise to a maximum in 1 to 5 weeks. Persons with higher basal tri glycerides and those consuming hypercaloric diets show the great est effect. Because the conversion of fructose to fatty acids proceeds unregulated, it contributes disproportionally to hypertri glyceridemia compared to other saccharides. In persons with type 2 diabetes, a high-carbohydrate diet tends to increase insulin resistance. Substitution of monounsaturated fats for the carbohy drate improves insulin resistance and lipoprotein levels. Women of childbearing age should be advised of the potential risk of teratogenicity of hypolipidemic agents. Estrogen-containing contraceptives should be avoided or used wirh caution in patients with hypertriglyceridemia. In children, hyperlipidemias other than primary hypercholes terolemias and severe cases of the metabolic syndrome may not require medication before age 16 years. Dietary treatment is indicated for all children with hyperlipidemia and should be started after the second year. The exception is primary chylomicronemia, in which an appropriate diet should be insti tuted as soon as the disease is detected. Those found in fish oils have special properties relevant to the treatment of hypertriglyceridemia and may protect against fatal arrhythmias in ischemic myocardium. C-reactive protein, lipoprotein-associated phospholipase A2, and other emerging biomarkers are useful in predicting risk. Moder ate use of monounsaturated fats such as olive oil, oleic acid-rich safflower oil, or canola oil is indicated. Caffeine and sucrose have negligible effects on serum lipids, and their statistical relationship to coronary heart disease is gener ally unimpressive when data are corrected for cigarette smoking. However, when coffee is prepared by protracted boiling of the grounds, a lipid substance (cafestol) is extracted that contributes to hypercholesterolemia. Treatment should commence at one-half this dosage to eb oo ks fre Dietary treatment is an important aspect of the management of all forms of lipoprotein disorders and may in some cases be all that is required. An exception is phytosterolemia in which the specific exclusion of dietary phytosterols and commercial products con taining phytosterols is indicated. This, and certain other mutations, may lead to significantly elevated levels of a metabolite of methionine-homocysteine-that has toxic effects on endothelium. Dietary protein should be restricted to the amount required for replacement of essential amino acids (about 0. Oral admin istration of betaine, a methyl donor, can reduce homocysteine levels in severely affected patients (2 g 3 times daily). Homocyste ine liberates the (a) protein from the Lp(a) complex, increasing its inhibition of fibrinolysis by plasminogen. Thus, the detection and management of hyperhomocysteinemia is important in patients with elevated Lp(a). Vitamin C assists this activity by restoring the tocopheroxyl radical to active tocopherol. These vitamins have been shown to restore normal vascular reac tivity in hyperlipidemic patients, and some epidemiologic evi dence suggests that they have an antiatherogenic effect. Larger doses may partially vitiate the effects of certain hypolipidemic drug regimens and have not been shown to have antiatherogenic potential. Selenium may also be important because it is a cofactor for one species of superoxide dismutase. Diets rich in fruits and vegetables appear to be important, providing isoflavones, quinols, and a number of carotenoid species. Olive oil contains a potent antioxidant, tyrosol that may be an important micronutrient. However, a basic diet is useful in the treatment of most patients, the elements of which are as follows: ks fre fre. They are not absorbed and, therefore, increase the excretion of bile acids in the stool up to tenfold. These agents can contribute an incremental effect in the management of insulin resistance by an incretin-mediated mechanism. When given as a single agent, a modest reduction in new coronary events can result. When given in combined regimens with a statin and/ or niacin, regression of coronary artery plaques has been demon strated by quantitative angiography. It increases sterol excretion acutely, mobilizes cholesterol from tissue pools until a new steady-state is established, and decreases cholesterol biosynthesis. That it can cause a continued decrease in hepatic cholesterol production even when given with bile acid-binding resins is probably an important feature of the complementary action of these agents. Niacin stimulates production of tissue plasminogen activator, an effect that may be of value in preventing thrombotic events. As a single agent, it was given in only one large intervention study which found a significant decrease in nonfatal, recurrent coronary events. In four angiographic studies in which niacin was given with a resin, a statin, or both, significant regression or decreased progression of coronary lesions was reported. For other forms of hypercholes terolemia, dysbetalipoproteinemia, hypertriglyceridemia, and. Patients frequently complain of a bloated sensation and constipation, both of which may be relieved by the addition of psyllium to the resin mixture. Malabsorption of fat or fat-soluble vitamins with a daily dose of resin up to 30 g occurs only in indi viduals with preexisting bowel disease or cholestasis. Hypopro thrombinemia has been observed in patients with malabsorption due to these causes. Cholestyramine and colestipol bind thyroxine, digitalis glycosides, and warfarin and impair the absorption of iron, thiazides, beta-blockers, ezetimibe, and other drugs. Absorption of all these (except ezetimibe) is ensured if they are administered 1 hour before or at least 2 hours after the resin. Because they change the composition of bile micelles, bile acid sequestrants theoretically may increase the risk of cholelithiasis, particularly in obese subjects. The resins should not be used as single agents in patients with hypertriglyceridemia and should be avoided in those with diverticulitis. In a group of patients treated continuously for up to 1 5 years, no significant liver disease developed despite such enzyme abnor malities. Rarely, patients develop a chemical hepatitis signaled by malaise, anorexia, and nausea. Aminotransferase levels are signifi cantly elevated, and levels of lipoproteins may fall precipitously. About one-fifth of patients have mild hyperuricemia that tends to be asymptomatic unless the patient has had gout. The use of niacin should be considered carefully in patients with insulin resistance. A more common side-effect is gastric irritation, which responds well to H2 blockers and antacids. Rarely, patients develop acanthosis nigricans, which usu ally clears if the drug is discontinued. A principal metabolite of niacin is N-methylnicotinamide, the formation of which consumes methyl groups resulting in the production of macrocytic erythro cytes that are without apparent inimical effect. Niacin should be avoided in patients with peptic ulcer or hepatic parenchymal disease. Liver function, uric acid, and blood glucose should be evaluated before commencing treatment and periodically thereafter. Most over-the-counter sustained-release preparations should be avoided because of the risk of fulminant hepatic failure. How ever, if the daily dose is limited to 2 g or less, this rare consequence is probably unlikely. Because niacin causes cutaneous flushing, it is usually started at a dosage of 1 00 mg 3 times daily with meals, increasing to the desired dose within 7 to 10 days. Many patients have no or only occasional flushing when stabilized on a given dose, but most must reach about 3 g/d before flushing ceases. It is important to counsel the patient that the flush ing is a harmless cutaneous vasodilation and that the drug should be taken with meals 2 or 3 times daily. Niaspan, a prescription extended-release niacin, appears to be safe in doses up to 2 g daily. Of these, lovastatin, pravas tatin, simvastatin, fluvastatin, atorvastatin, pitavastatin, and rosu vastatin are approved for use in the United States. These drugs have no appreciable effect in patients with severe these agents are generally well tolerated. Among the rare hypersensi tivity syndromes (Lupus-like syndromes and dermatomysitis) associated with statin treatment, is a more recently described autoimmune myopathy. Other drugs that compete for metabolism by cyto chrome P450 3A4 can be expected to have the same effect. Because pravastatin and rosuvastatin do not compete with these agents for metabolism by cytochrome P450 enzymes, they appear to be compatible with them. Thus, competitors for that pathway may cause accumulation of this reductase inhibitor. Skin eruptions, gastrointestinal symptoms, and muscle symptoms have been described as well as blood dyscrasias and elevated levels of aminotransferases and alkaline phosphatase. These drugs enhance the effects of the coumarin and indanedione anticoagu lants and increase lithogenicity of bile. Concomitant use of fibrates with certain reductase inhibitors increases the risk of myopathy. Fenofibrate is most compatible with pravastatin or rosuvastatin with respect to cytochrome metabolism. Fibrates should be avoided during pregnancy and lactation and are contra indicated if renal or severe hepatic disease is present. Their effects are amplified signifi cantly when combined with niacin, ezetimibe, or resin. Because information on long-term safety is lacking, use of these agents in children should be restricted to those with homozygous hypercholesterol emia and selected heterozygotes who are at particularly high risk. Women who are lactating, pregnant, or likely to become pregnant should not be given these drugs. One primary prevention, and one secondary prevention trial using gemfibrozil as monotherapy showed reduction in new coronary events. Some of the cholesterol-independent effects of reductase inhibitors appear to involve enhanced stability of atherosclerotic lesions and decreased oxidative stress and vascular inflammation, with improved endothelial function. Institution of treatment with a reductase inhibitor should begin immediately in all patients with acute coronary syndromes regardless of choles terol level. A number of primary and secondary trials with statins as monotherapy have demonstrated significant reduction in end points including primary or recurrent myocardial infarction, coro nary revascularization, atherosclerotic stroke, or cardiac death. The prevalence of ele vated liver enzymes may be modestly increased when ezetimibe is the most significant adverse effect is hepatic steatosis that reverses spontaneously in some patients. Concomitant use of fibric acid derivatives can increase the blood concentration of this drug. It should be avoided in pregnant or lactating women and in patients with liver disease, and used with caution in patients receiving cydosporine. By interrupting the entero hepatic circulation of sterols secreted in bile, it increases sterol elimination. Recent trials indicate that ezetimibe contributes to reduction of new coronary events. Moderate, often intermittent elevations of serum aminotrans ferases (up to 3 times normal) occur in some patients. If the patient is asymptomatic, therapy may be continued if activity is measured frequently (at 1- to 2-month intervals) and the levels are stable.

Reoperation for recurrent disease in the neck is successful about 90% of the time erectile dysfunction on molly avana 200 mg buy with amex, whereas autograft removal is successful in about 60% of patients erectile dysfunction pump pictures order 100 mg avana mastercard. Sup pression of gastric acid production with proton pump inhibitors (eg erectile dysfunction treatment without medication avana 50 mg buy low cost, omeprazole) remains a mainstay of therapy impotence word meaning purchase generic avana canada. Conservative medical management of these tumors has been predicated on their assumed low-grade malignant behavior erectile dysfunction at age 31 avana 100 mg on line, the dominance of compli cations related to gastric acid hypersecretion in contributing to morbidity and mortality, and the failure of most attempts at surgi cal resection to alter the natural course of the disease. More recently, recognition of the potential for more aggressive behavior in some of these tumors-in a recent study, 14% of these tumors demonstrated aggressive growth-and the fact that many of these m. A number of small studies have reported encouraging results when measures to both localize and remove gastrinoma tissue in the pancreas, duo denum, and regional lymph nodes have been used. Although the nature of the underlying genetic lesion and the multicentricity of these tumors may place limits on the prospects for cure of this disease in most patients, the slow growth characteristics of these tumors permit long periods of symptom-free survival following reduction of the tumor burden. For patients with liver or other metastatic disease, symptoms related to hypergastrinemia may be controlled with the proton pump antagonists, as described earlier. More conventional cancer therapy (eg, systemic chemotherapy, radiation therapy, or selective chemoembolization of hepatic metastases) is palliative and reserved for advanced stages of the disease. Islet tumors more than 3 em carry an increased risk of malignancy and are usually resected regardless of functional status. Therefore, a more aggressive approach can be directed toward the pancreas in planning surgical resection. Enu cleation of the identifiable lesions in the pancreatic head and blind resection of the pancreatic body and tail are often successful in correcting hyperinsulinemia. Nonsurgical candidates (eg, those with serious coex isting disease or those in whom candidate tumors cannot be identified) can be managed with conventional medical therapy (eg, diazoxide or verapamil) (see Chapter 1 8). Surgical efforts to minimize spread of metastases are weighed against the need to avoid incurring surgical complications, including mortality, with little clinical benefit. The frequency of germline mutations in the Men] gene in patients with tumors thought to be sporadic based on family analysis is about 5% for gastrinomas and 1 o/o to 2% for other manifestations (eg, hyperparathyroidism, prolactinomas). Identifica tion of the carrier state should be performed with the intent of acquiring information that allows the clinician to focus screening on the relevant patient population (eg, members of affected kin dred who do not share the Men] gene mutation need not be subjected to follow-up screening). Such interventions (eg, pancreatic exploration) may be associated with significant morbidity, and there is no evidence that they prolong patient survival. A complete examination and full family history should be obtained on all patients. In kindreds in whom the disease is particularly aggressive, the secretin stimula tion test (if available) can lend additional diagnostic sensitivity. Pancreatic polypeptide measurements may identify an unsuspected pancreatic neuroendocrine tumor. As noted earlier, pan creatic neuroendocrine lesions are typically multifocal and may be very small, which make detection difficult even with sophisticated imaging studies. In the absence of obvious clinical findings (eg, evidence of a hyper or hyposecretory state or symptoms referable to a mass lesion in the sella turcica), routine screening should be confined to periodic measurements of serum prolactin and perhaps insulin-like growth factor-1. The former has been found to be useful in identifying pituitary disease in females harboring the Men] gene defect. A thorough family history that excludes pituitary disease in the kindred may mitigate the need for pituitary imaging studies over the long term. If there is no evidence of typical endocrine organ involvement by that age, screening frequency might be reduced. A minority of patients presents with their first manifestation of the syndrome well after age 45. Surgical resection of diseased tissue (eg, parathy roidectomy) should be followed with continued screening looking both for recurrent disease and involvement of other organ systems. These lesions respond to pentagastrin or calcium infusions with significant increments in plasma calcitonin levels (see Chap ter 8). Occasionally, immunohistochemical staining of poorly differentiated thyroid tumors for calcitonin reveals the identity of the malignancy. The presence of extracellular amyloid is also one of the identifying features of these tumors. This material reacts with anticalcitonin antisera, suggesting that it includes aggregated hormone released from neighboring tumor cells. Subsequent refine ment in these analyses indicated that the defective gene was either closely linked to or identical with the ret proto-oncogene. Distant metastases to liver, lung, and bone occur late in the course of the disease. They are usually located in the adrenal bed, often are bilateral, and are rarely malignant. Cutaneous lichen amyloidosis is thought to result from an abnormality in cutaneous innervation that leads to hyperesthesia and pruritis. Repeated scratching of the pruritic area results in epidermal thickening and increased pigmenta tion. The intestinal lesions can disrupt gut motility, resulting in periods of severe constipation or diarrhea. It should be noted that the Cys-to-Arg mutation at position 634 is also the most common mutation at this position, accounting for about 64% of all codon changes at this location. Instead, the majority possess a single-point mutation involving 1 1 conversion of Met9 8 to Thr9 8. A minority of patients have been 3 3 shown to harbor an independent mutation of Ala88 to Phe 88, ks f ok s ks oo oo eb o eb eb eb oo ks ks fre fre. For unknown reasons, these mutations are found almost exclusively on the paternal allele. Given the multicen tric nature of the disease, subtotal thyroidectomy predictably results in recurrent disease. Basal or stimulated calcitonin levels are used in the postoperative setting to evaluate the presence of residual disease. The presence of a thyroid nodule or lymph node metastases at the time of diagnosis is strongly associated with persistent or recurrent disease and low rate of cure. Some have suggested that surgery in these patients can be deferred until plasma calcito nin levels (basal or stimulated) are elevated. Patients should always be screened for the presence of pheochromocytoma before under going neck exploration. Surgery for metastatic disease is palliative and targeted at reducing tumor burden rather than cure. Recent randomized, double blind, phase 3 clinical trials involving the tyrosine kinase inhibitors vandetanib and cabozantinib have shown significant improvement in progression-free survival in patients treated with these agents. These agents (van detanib and cabozantinib) provide objective response rates of 45% and 28%, respectively, when compared with placebo. Alpha- and (occasionally) beta-adrenergic blockade is used to control blood pressure and associated hyperadrenergic symptoms and to restore normal intravascular volume in preparation for surgical resection of the tumor. Given the propensity for bilaterality of pheochromo cytomas in this disorder, some have favored bilateral adrenalec tomy at the time of initial surgery. This vigilant approach has the advantage of minimizing morbidity from recurrent pheochromocytoma while sparing the patient the risks associated with lifelong adrenal insufficiency. Biochemical testing using basal or stimulated plasma calcitonin levels has been largely supplanted by genetic screens. The biochemical tests remain useful, however, in identifying residual disease after thyroidectomy. Controversy persists, how ever, in terms of what should be done for patients once the muta tion has been identified. Some investigators citing incomplete clinical penetrance (according to published data, 40% of gene carriers do not present symptomatically prior to age 70) have argued that employing solely genetic criteria in making the deci sion for operative intervention subjects a small minority of patients to premature thyroidectomy. They argue that genetic testing should be used to identify those patients who require close clinical and biochemical surveillance to assist with the timing of surgery. Genetic considerations for patients presenting with seemingly sporadic pheochromocytoma are discussed in Chapter 1 1. Collectively, these findings point out the relative deficiencies of biochemical versus genetic testing and offer a compelling argument for early operation as a means of reliably eradicating the disease. Patients at the next level (ie, C634R/F/S/W/Y) should be screened in the first years of life and operated before age 5. Routine screening for pheochromocytoma and hyperparathyroidism in individuals at risk can typically be initiated later, but all patients undergoing thyroidectomy should have pheochromocytoma ruled out first. How ever, affected individuals also develop tumors or nodular hyperpla sia of a number of endocrine glands with associated hypersecretory syndromes. One may see involvement of the pituitary somato trophs (acromegaly), thyroid gland (hyperthyroidism), or the adrenal cortex (hypercortisolemia). Patients with McCune Albright syndrome frequently demonstrate hypophosphatemic rickets. This is thought to result from secretion of fibroblast growth factor-23 that is produced in the mesenchymal cells associ ated with the dysplastic bone lesions. They also have nonendo crine organ involvement that leads to cardiomyopathy with sudden death and liver function abnormalities. This somatic mutation is thought to occur early in development, leading to genetic mosaicism for the mutant allele. Myxo mas of the heart, breast, and skin are seen frequently in this disorder, as is spotty pigmentation of the skin (lentiginosis) and ear canal trichofolliculo-epitheliomas. Additional rare manifesta tions include psammomatous melanotic schwannoma, breast ductal adenoma, and osteochondromyxoma. In approximately two-thirds of the known Carney complex kindreds, the genetic lesion maps to 1 7q22-24, a locus that harbors the type 1A regulatory subunit of protein kinase A. This gene functions as a classic tumor suppres sor, and loss of heterozygosity at this locus is associated with the Carney phenotype. A second locus, presumably accounting for some fraction of the remaining half of Carney complex kindreds, is located at 2p 1 6. The nature of the genetic lesion at this locus remains unknown at present; however, the phenotype is indistin guishable from that found with the 1 7q22-24 mutations alluded to above. The presence of pheochromocytomas and most of the islet cell tumors is confined to the type 2 variant of the disease, which accounts for 25% to 35% of affected kindreds. The von Hippel-Lindau protein, which is normally encoded by this locus, participates in the formation of a multi protein complex involved in the regulation of hypoxia-induced gene transcriptional activity, fibronectin matrix assembly, and ubiquitin ligases. Menin associates with a tritho rax family histone methyltransferase complex and with the Hoxc8 locus. The characterization of pheochro mocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 1 67 carriers of the Ret germ line mutations. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A. These services including use of agents to block endogenous puberty at Tanner stage 2 with subsequent use of cross-sex hor mones are based on longitudinal studies demonstrating that those individuals who were first identified as gender dysphoric in early or middle childhood and continue to meet the mental health cri teria for being transgender at early puberty are likely to be trans gender as adults. The goals of Part I of this chapter are to review terms and definitions applicable to gender nonconforming youth (and adults), endocrine, genetic and neuroanatomical studies that shed light on the biologic underpinnings of gender identity and to review the natural history of transgenderism, current clinical prac tice guidelines for transgender youth, and limitations and chal lenges to optimal care. Most children, at birth, are assigned a "sex of rearing" (some mental health providers prefer the term "gen der of rearing") based on genital anatomy. As defined by the American Psychiatric Asso ciation, "transgender" refers to a person who transiently or persis tently identifies with a gender different from their "natal gender. The terms "gender queer," "gender variant," "gender expansive," "gender creative," or "gender independent" are increasingly used to describe individuals who state that their gender identities are nei ther male nor female. Some of these individuals accept their assigned genders but not the cultural expectations for those genders. In this context, it is not dear whether core gender identity is, in fact, changing, or whether gender fluidity reflects an ongoing process of self-awareness. Replacing "dis order" with "dysphoria" depathologizes the transgender identity, and instead, focuses on dysphoria as the clinical problem. As with cis gender individuals, gender nonconforming/transgender individu als may have a heterosexual, homosexual, or bisexual orientation. Preva lence of Tra n sgenderism in Youth Numerous studies from a variety of biomedical disciplines endocrine, genetic, and neuroanatomical-have begun to shed light on the biologic underpinnings of gender identity. Results of these studies support the concept that gender identity is not sim ply a psychosocial construct, but likely reflects a complex interplay of biologic, environmental, and cultural factors. Of note, there was no appar ent correlation with the degree of genital masculinization and gender identity outcome. A retrospective cohort study of 1 80 transgender individuals aged 12 to 29 years seen in a Boston clinic between 2002 and 20 1 1 were compared to an equal number of cis-gender, age-matched controls. In comparison to controls, transgender youth/young adults had a two- to threefold increased risk of anxiety, depression, suicidal ideation, suicide attempts, and self-harm without lethal intent. The impact of the degree of parental support on mental health outcomes was reported in a cohort of transgender youth and young adults age 1 6 to 24 years (n 84) from Ontario, Canada: Satisfaction with life and self esteem were significantly greater in transgender youth whose par ents were "very supportive" versus those whose parents were "somewhat to not at all supportive. Even with supportive parents, transgen der youth still have a significant risk for depression, perhaps in part from their experience of transphobia from members of their communities and feelings of rejection and social isolation. In addition, of 1 6 males with penile agenesis assigned female at birth and of 7 males with penile ablation reassigned to female in infancy or early childhood, the majority were living as female. While gender fluidity may be a contributing factor, the lack of persistence of gender dysphoria in the majority of gender dysphoric prepubertal youth likely reflects the heteroge neous nature of this group. Many such individuals will turn out to be homosexual (natal males, in particular) rather than transgender. Investigators have attempted to identify factors that predict gender dysphoria "persisters" versus "desisters. In addition, persisters believed they "were" the other sex, while desisters "wished they were" the other sex. With respect to genetics and gender identity, heritability of transsexualism has been suggested primarily from studies describ ing concordance of transsexualism in monozygotic twin pairs.

Professional judgment should be used when determining the area to count on the hemocytometer erectile dysfunction treatment canada cheap 100 mg avana. The center square millimeter may be sufficient for accurate counts when the sperm concentration is high erectile dysfunction pills in south africa buy avana 50 mg otc. Otherwise erectile dysfunction treatment ayurveda generic avana 200 mg buy, it may be neces sary to count the four corner square millimeters or even one entire side of the hemocytomer (nine square millimeters) for accurate counts when the sperm concentration is low erectile dysfunction cure avana 100 mg order on line. Following the rules for hemocytometer counting needs pro fessional judgment as well erectile dysfunction drugs medications avana 200 mg otc, because sperm do not always lie entirely inside or outside the counting area. What usually works best is to determine the placement of the sperm heads on the hemocytometer grid rather than the tails. The count is mul tiplied by ten before dividing by the area to account for the depth between the coverslip and the counting chamber surface. For example, if the number of sperm counted in nine square millimeters on a 1: 1 00 dilution is 25, the calculation is (25 x 1 00 x 1 0)/9 2,778/mm3. Sperm concentration is often reported in number per cubic centimeter (cc) or milliliters (mL). Therefore, multiplying by 1,000 is necessary to convert the count to the correct unit. Normal sperm concentrations have been reported to range between 20 and 250 million per milliliter. Sperm counts less than normal may be due to chromosomal disorders, ductal obstruc tion, drugs, gonadotropin deficiency, hyalinization of the seminiferous tubules, maturation arrest, pituitary disorders, radiation, renal failure, and Sertoli-cell-only syndrome. Hor mone tests, discussed later in this chapter, may help differenti ate among the various causes of azoospermia. Fertility, however, is possible at counts as low as 1 million sperm per milliliter. Of greater importance in the analysis of semen for fertility evaluation are other microscopic tests. Tests that have a greater bearing on fertility include morphology (physical characteristics), motility (degree of forward move ment), penetration (ability to move through mucous), and viability (proportion of live sperm). At least 80% of the sperm demonstrate some forward progress in a normal semen sample. An alternate method used by some fertility clinics is to evaluate sperm motility from a video record ing that is played back with a grid overlaying the monitor. More recent use of technology for sperm evalua tion includes the use of high-resolution video photography in combination with computer programs that can calculate velocity, linear progression, and motility efficiency and mea sure patterns of sperm motion. Motility can be affected by temperature and other factors, such as the presence of antisperm antibodies. Therefore, a viability test should be performed, especially if a high number of nonmotile sperm are present. Agglutination Fertilization of an ovum is dependent on the ability of sperm to reach and unite with it. Motility should be evaluated within 1 hour of specimen collection, because motility will decrease over time. One way to evaluate sperm motility is to place a small drop of liquefied semen on a prewarmed slide and cover slip. Some laboratories prefer to use phase contrast microscopy while evaluating sperm motility, however, bright light microscopy with the condenser turned down is adequate. The movement of sperm is evaluated and may be sub j ectively estimated or counted into three categories. These categories may be called high-motile, low-motile, and non motile; or progressive, nonprogressive, and nonmotile. Some laboratories may use as many as five categories: nonmotile, nonprogressive, slow nonlinear progression, moderate linear progression, and strong linear progression. Some laborato ries report the percent of sperm in each category; whereas others Agglutination (clumping) of sperm may be observed while evaluating a wet mount of semen for sperm motility. A few clumps of sperm or sperm sticking to mucus or other cells can normally be seen in a semen sample. However, true agglutination is present if sperm are distinctly clumped head to head or tail to tail, which may indicate the presence of antisperm antibodies. Both IgG and IgA antibodies have been found in the semen of some men with reduced fertility whose sperm demonstrate agglutination. Confirmation with immu nologic tests can help determine the specific type of antibody. Viability Determining whether nonmotile sperm are viable or nonvia ble is important in establishing a cause for infertility in males. The membranes of viable sperm remain intact and do not allow eosin stain to penetrate, leaving the sperm colorless (they will appear white). Eosin stain can be Chapter 1 6 Semen Analysis 237 incapable of penetrating through cervical mucus. Some phy sicians consider penetration to be the most important param eter to evaluate in the investigation of infertility. The presence of many motile sperm contained in this specimen is evidence for normal penetration ability. A commercially produced product for evaluating sperm p enetration, Penetrak, is not currently available and is discussed in Appendix D. The smear may be made by placing a drop of semen on a slide, placing another slide on top, and pulling them apart in opposite directions. The smear may be fixed with a cytology fixative and then stained with Papanicolaou stain. Sperm morphol ogies are classified by counting 1 00 to 200 sperm using oil immersion. Nigrosin provides a dark background against which the red-colored dead sperm and the white or colorless sperm can be visual ized. At least 1 00 sperm heads are counted into two categories: red dead and white viable. However, the propor tion of motile sperm should not be higher than the proportion of viable sperm. Penetration Even though sperm may be viable and motile, a couple can still be experiencing male infertility problems if the sperm are A normal spermatozoon has a flattened oval head and an elongated tailpiece. The head appears oval when viewed from the front and appears pyriform when viewed from the side. Four distinct regions comprise the tailpiece: neck piece, midpiece, main piece, and endpiece. Abnormal sperm morphology occurs as an anomaly of either the head or the tailpiece, or both. Head anomalies include acrosomal abnormalities, constricted heads, double-headed or double-nucleated heads, enlarged or pinheads, nuclear abnor malities, and vacuolation. Tailpiece anomalies include coiled tailpiece, cytoplasmic extrusion mass, lengthened or bent neck piece, midpiece abnormalities, multiple tails, and variation in tail length. I n addition, greater than 2 % immature spermatozoa may be present during testicular stress, after a viral infection, and as a result of heavy alcohol consumption. Immature spermatozoa may resemble leuko cytes and must be properly identified to avoid misdiagnosis of infection. Urethral epithelial cells and white blood cells are usually present in low numbers and can be seen during the hemocytometer count and on morphology smears. An increased number of neutrophils indicates an infection or inflammatory process. Red blood cells are not normally pres ent in semen and should be reported if seen. In addition, bac teria are not a normal finding in seminal fluid and should also be reported. Acidic semen pH may be seen in congenital aplasia of vasa deferentia and seminal vesicles, while a male reproductive tract infection produces an alkaline pH. Fructose Semen acid phosphatase is used to evaluate the secretory function of the prostate. Normal levels of acid phosphatase are equal or greater than 200 units per ejaculate. Semen fructose is produced by the seminal vesicles, with normal levels being equal or greater than 13! Low semen fructose levels have been found to correlate with androgen deficiency, decreased testosterone levels, and genital tract inflammation. In addi tion, the absence of fructose may indicate ejaculatory duct obstruction, seminal vesicle dysfunction, or hypoplasia. Gonadotropin deficiency demonstrates decreased levels of all three of these hormones. These hormone levels are normal if the cause of azoospermia is ductal obstruction or maturation arrest. The presence of Se in semi nal plasma has positive effect on sperm count, motility, and morphology. Selenium has been found to be deficient in men with varicocele (dilatation of pampiniform venous plexus of the spermatic cord). Iron (Fe) may affect sperm morphology as it has been found to be higher in teratozo ospermic males. Kibrick Method the Kibrick method involves incubating fresh, liquefied semen with serum from the male or serum from his female partner. Neutral alpha-glucosidase, secreted by the epididymis, may affect semen volume and pH. In addition, carnitine and glycerolphosphocholine are markers of epididymal function. Citric acid (citrate) is responsible for the pH of semen and correlates with the physiological function of the prostate gland. In addition to fructose, certain prostaglandins are made in the seminal vesicles and are useful in their evaluation. Comparison is made between sperm motility of fresh, lique fied semen and that of semen incubated with either rabbit or guinea pig complement. A sperm immobilization value is cal culated by dividing the percent of motile sperm in the fresh specimen by the percent of motile sperm in the incubated sample. These assays can determine whether antisperm antibodies are directed against head, mid piece, or tail and whether the antibodies are IgA, IgG, or IgM. In addition, the immunobead assay method allows for calculating the proportion of sperm in an ejaculate that is antibody bound. These antibodies may be individual specific or may be reactive to all human spermatozoa. What type of container should be provided for the col lection of a semen specimen Polymorphonuclear granulocyte elastase Which test is useful in evaluating the function of the epididymis Superoxide dismutase activity An asthenozoospermic semen is one that displays a: a. Normal sperm count and motility but less than normal morphology What substance(s) can help establish the presence of semen Explain the correlation between the low number of motile sperm and the number of viable sperm. Impact of seminal trace element and gluta thione levels on semen quality of Tunisian infertile men. Selenium, copper and zinc in seminal plasma of men with varicocele, relationship with seminal param eters. What may be an explanation for these abnormal results with the remaining tests being normal Bioi zinc and iron concen tration and sod activity in human semen and seminal plasma. Candida albicans and filtrates interfere with human spermatozoal motility and alter the ultrastructure of spermatozoa: an in vitro study. Relationship between semen quality and seminal plasma components: alpha-glucosidase, fructose and citrate in infertile men compared with a normospermic population of Tunisian men. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population. Compare and contrast the amniotic fluid testing available for fetal lung maturity. Discuss the risks for the fetus in preterm delivery and explain assessment of fetal risk using the Liley graph. This fluid serves to cushion and protect the developing fetus and also serves a key role in the exchange of water and molecules between the fetus and the maternal circula tion. The lab oratory performs several crucial tests on amni otic fluid to assess the status of the fetus. Tests for the presence of amniotic fluid in vaginal secretions are discussed in the Chapter 1 8. An atomy an d Physiology of Amn iotic Fluid Formation the amniotic fluid is formed from the placenta. Amniotic fluid has a composition similar to that of the maternal plasma with a small number of cells from the skin, urinary tract, and digestive tract of the newborn and biochemical substances produced by the fetus. The volume of amniotic fluid increases steadily throughout the pregnancy up to a maximum of 1, 1 00 to 1,500 mL at 36 weeks of gestation. When fetal urine production begins, the chemical compo sition of the amniotic fluid changes. This change corresponds to the increased production of creatinine at about 36 weeks of gestation.

Buy discount avana 200 mg on-line. Erectile Dysfunction Home Remedy Hindi | स्तंभन दोष (ED) | Acupressure Points.

Hypoperfusion and hypoxia are likely both a cause and effect of abnormal placental vascularization and subsequent preeclamp sia erectile dysfunction at age 21 200 mg avana visa. Animal models support this theory as induced preeclampsia generally requires mechanically reduced ureroplacental perfusion viagra causes erectile dysfunction avana 50 mg buy low price. In addition erectile dysfunction doctor in philadelphia avana 200 mg sale, maternal medical conditions associated with vascular dysfunction such as hypertension severe erectile dysfunction causes avana 100 mg purchase line, lupus impotence guide generic 50 mg avana visa, and renal disease increase the risk of preeclampsia, as do obstetric conditions that increase placental volume without increasing placental blood flow, such as twins and hydatidiform moles. Generalized endothelial dysfunction may explain many of the multiple clinical features of preeclampsia. Extensive placental angiogenesis is required to supply the nec essary nutrients and oxygen to the fetus. However, pregnancies between 24 and 34 weeks are more compli cated as the obstetrician must balance the significant perinatal morbidity and mortality associated with preterm delivery versus the maternal and fetal risk of prolonging these high-risk pregnan cies. Antihypertensive medications should be used in setting of severe hypertension to prevent a maternal stroke; however, their use in mild to moderate hypertension has not been shown to improve maternal or fetal outcome. Magnesium sulfate therapy is initiated as the anticonvulsant of choice for preeclamptics during labor, while administering corticosteroids prior to a planned pre term delivery, and for 24 hours postpartum. Despite knowledge of the many risk factors described above, it is still not possible to determine which mothers will ultimately develop pre eclampsia and there are no effective preventative treatments. Large clinical trials using calcium and antioxidant vitamin supplementa tion revealed minimal to no benefit in preventing the develop ment of preeclampsia. Although some clinical trials of low dose (8 1 mg/d) aspirin failed to show benefit, several meta-analyses support its use for prophylaxis. Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing Association of genetic vari ants, ethnicity and preterm birth with amniotic fluid cyrokine concentra tions. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth. Pregnancy as a window to future health: excessive gestational weight gain and obesity. Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. The renin-angiotensin system, its autoanti bodies, and body fluid volume in preeclampsia. The renal circulation in normal pregnancy and pre eclampsia: is there a place for relaxin Pre-eclampsia rates in the United States, 1 980-20 1 0: age-period-cohort analysis. Progesterone is not the same as 1 7a-hydroxyprogesterone caproate: implications for obstetrical practice. Whereas the major role of the products of the exocrine pancreas (the digestive enzymes) is the processing of ingested foodstuffs so that they become available for absorption, the hormones of the endocrine pancreas modulate every other aspect of cellular nutrition from rate of adsorption of foodstuffs to cellular storage or metabolism of nutrients. Dysfunction of the endocrine pancreas or abnormal responses to its hormones by target tissues cause serious distur bances in nutrient homeostasis, including the important clinical syndromes grouped under the name diabetes mellitus. The endocrine pancreas consists of approximately 1 million small endocrine glands-the islets of Langerhans-scattered through out the glandular substance of the exocrine pancreas. The exocrine pancreas consists of the enzyme-producing cells organized into acini, and the duct system that delivers those enzymes to the lumen of the duodenum. The posterior lobe receives its blood supply from the superior mesenteric artery; the remainder of the pancreas derives most of its blood flow from the celiac artery. These enzymes recognize and cut at pairs of basic amino acids, thereby removing the intervening sequence. A small amount of proinsulin produced by the pancreas escapes cleavage and is secreted intact into the bloodstream, along with insulin and C peptide. Most anti-insulin sera used in the standard immunoassay for insulin cross-react with proinsulin; about 3% to 5% of immunoreactive insulin extracted from human pancreas is actually proinsulin. Because proinsulin is not removed by the liver, it has a half-life three to four times that of insulin. Its long half-life allows proinsulin to accumulate in the blood, where it accounts for 1 2% to 20% of the circulating immu noreactive insulin in the basal state in humans. Of the two major proinsulin split products present in plasma, the one split at arginine 32-33 far exceeds in amount the barely detectable 65-66 split product. Proinsulin is transported to the Golgi apparatus, where packaging into clathrin-coated secretory granules takes place. Maturation of the secretory granule is associated with loss of the clathrin coating and conversion of proinsulin into insulin and a smaller connecting peptide, or C peptide, by proteolytic cleavage at two sites along the peptide chain. Mature secretory granules contain insulin and C peptide in equimolar amounts and only small quantities of proinsulin, a small portion of which con sists of partially cleaved intermediates. Each islet is sur rounded by a lattice of astroglial cells and innervated by sympa thetic, parasympathetic, and sensory neurons. O ·· ·· ··· ·· O······ ··· O ················ · ··············· ·················· O ····· · ···· The basal concentration of insulin in the peripheral blood of fasting humans averages 1 0 1-1U/mL (0. After ingestion of food, peripheral insulin concentration increases within 8 to 10 minutes, reaches peak concentrations by. In the basal state after an overnight fast, the average con centration of C peptide may remain as high as 1 000 pmoi! In addition, an intra chain disulfide bridge links positions 6 and 1 1 in the A chain. Basal insulin secretion occurs in the absence of exogenous stimuli, in the fasting state. L) do not stimulate insulin release, and most other physiologic regulators of insulin secretion only function in the pres ence of stimulatory levels of glucose. When the glucose concentration increases suddenly, an ini tial short-lived burst of insulin release occurs (the first phase); if the glucose elevation persists, the insulin release gradually falls off and then begins to rise again to a steady level (the second phase). How ever, sustained levels of high glucose stimulation (-4 hours in vitro or >24 hours in vivo) result in a reversible desensitization of the P cell response to glucose but not to other stimuli. Indeed, agents such as 2-deoxyglucose that inhibit the metabolism of glucose block the release of insulin. The low-affinity enzyme glucokinase catalizes the subsequent, and rate-limiting, step in glucose metabolism by the pancreatic P cell, the phosphorylation of glucose to glucose-6-phosphate. In addition to the voltage-dependent entry of extracellular Ca2 + into the p cell as described earlier, glucose also retards ci· efflux from the p cell and releases ci· from intracellular compartments (predomi nantly the endoplasmic reticulum) into the cytosol. Some nonglu cose stimuli of insulin release also function through increases in cytoplasmic ci·. Glucose metabolism in the P cell also generates additional signals that amplifY the secretory response to elevations in cytoplasmic Ca2 + concentration. Other factors involved in the regulation of insulin secretion are summarized in Table 1 7-2. These factors can be divided into three categories: direct stimulants, which directly raise cytoplas mic calcium ion concentrations and thus can act in the absence of stimulatory glucose concentrations; amplifiers, which potentiate the response of the P cell to glucose; and inhibitors. Many of the amplifiers are incretins: gastrointestinal hormones that are released in response to the ingestion of meals and stimulate insulin secre tion. The action of the incretins explains the observation that orally ingested glucose provokes a greater insulin secretory response than does the same amount of intravenously adminis tered glucose. Th is block of the K+ cu rrent depola rizes the cell, a l lowi ng the voltage-gated ca lcium channels to open. These activated substrates each lead to subsequent recruitment and activation of additional kinases, phosphatases, and other signaling molecules in a complex pathway that generally contains two arms: the mito genic pathway, which mediates the growth effects of insulin and the metabolic pathway, which regulates nutrient metabolism. These receptors bind insulin rapidly, with high specificity and with an affinity high enough to bind picomolar amounts. Insulin receptors, members of the growth factor receptor fam ily (see Chapter 1), are membrane glycoproteins composed of two protein subunits encoded by a single gene. The beta sub unit crosses the membrane, and its cytoplasmic domain contains a tyrosine kinase activity that initiates specific intracellular signal ing pathways. Insulin can simply disengage from the receptor, or the receptor can be inter nalized and degraded. Many of these mechanisms may play a role in the development of insulin resistance (discussed later). Foxo 1 coordinates the expression of gene networks involved in nutrient metabolism in multiple tissues, generally activating genes involved in the response to fasting. They may function as targets of insu lin signaling, modulators of insulin signaling, or both. Insulin promotes anabolism-Insulin promotes glycogen synthesis and storage while inhibiting glycogen breakdown. These effects are mediated by changes in the activity of enzymes in the glycogen synthesis pathway (discussed later). The liver has a maximum storage capacity of 1 00 to 1 1 0 g of glycogen, or approximately 440 kcal of energy. It also inhibits gluconeogenesis and promotes glycoly sis through its effects on the function and expression of key enzymes of both pathways. Insulin inhibits catabolism-Insulin acts to reverse the catabolic events of the postabsorptive state by inhibiting hepatic glycogenolysis, ketogenesis, and gluconeogenesis. Muscle-Insulin promotes protein synthesis in muscle by increasing amino acid transport, as well as by stimulating ribosomal protein synthesis. In addition, insulin promotes glycogen synthesis to replace glycogen stores expended by muscle activity. This is accomplished by increasing glucose transport into the muscle cell, enhancing the activity of gly cogen synthase, and inhibiting the activity of glycogen phos phorylase. Approximately 500 to 600 g of glycogen are stored in the muscle tissue of a 70-kg man, but because of the lack of glucose 6-phosphatase in this tissue, it cannot be used as a source of blood glucose, except for a small amount produced when the debranching enzyme releases unphosphorylated glucose from branch points in the glycogen polymer, and the glucose indirectly produced via the liver from lactate gener ated by muscle. Adipose tissue-Fat, in the form of triglyceride, is the most efficient means of storing energy. In the typical 70-kg man, the energy content of adipose tissue is about 1 00,000 kcal. Insulin acts to promote triglyceride storage in adipocytes by a number of mechanisms. This reduction of fatty acid flux to the liver is a key regulatory factor in the action of insulin to lower hepatic gluconeogenesis and ketogenesis. Central nervous system-Although the brain is traditionally not considered an insulin-sensitive tissue, and overall glucose utilization by the brain is not acutely regulated by insulin, key regions of the brain can respond to insulin. The effects of the products of endocrine cells on surrounding cells are termed paracrine effects, in contrast to actions that take place at sites distant from the secreting cells, which are termed endocrine effects (see Chapter 1). In addition, soma tostatin, which 8 cells release in response to most of the same stimuli that provoke insulin release, also inhibits glucagon secretion. Because glucose stimulates only p and 8 cells (whose products then inhibit a cells) whereas amino acids stimulate glucagon as well as insulin, the type and amounts of islet hormones released during a meal depend on the ratio of ingested carbohydrate to protein. The higher the carbohydrate content of a meal, the lower the amount of glucagon released by any amino acids absorbed. In contrast, a predominantly protein meal results in relatively greater glucagon secretion, because amino acids are less effective at stimu lating insulin release in the absence of concurrent hyperglycemia but are potent stimulators of a cells. Pa racrine effects eb function of almost every tissue in the body, the discussion here will be limited to a brief overview of the effects of insulin on the major tissues specialized for energy metabolism: liver, muscle, adipose tissue, and brain. At the level of the individual cell, however, additional mechanisms sense and respond to the local energy state. Because cell membranes are impermeable to hydrophilic molecules such as glucose, all cells require carrier pro teins to transport glucose across the lipid bilayers into the cytosol. All cells utilize non-energy-dependent transporters that facilitate diffusion of glucose from a higher concentration to a lower con centration across cell membranes. The first four members of the family are the best characterized, and they have distinct affinities for glucose and distinct patterns of expression. Islets of nondiabetic elderly persons may contain less extensive amyloid deposits. Whether amyloid fibrils and deposition contrib ute to the islet dysfunction and cell loss seen in type 2 diabetes or are simply a consequence of disordered and hyperstimulated islet function remains an unresolved question. It mediates basal glu cose uptake, because it has a very high affinity for glucose and, therefore, can transport glucose at the relatively low concentra tions found in the fasted state. For this reason, its presence on the surface of the endothelial cells of the brain vascular system (blood-brain barrier) ensures adequate transport of plasma glu cose into the central nervous system. It also has a very high affinity for glucose and is responsible for transferring glucose into neuronal cells at the lower concentrations found in the central nervous system. It is a major transporter of glucose in hepatic, intestinal, and renal tubular cells. The intestine and kidney also have energy-dependent Na+ glucose cotransporters capable of transporting glucose against its concentration gradient. The activity of prohormone convertase 2 in a cells gener ates the glucagon peptide, along with the amino-terminal glicen tin-related peptide, a small central hexapeptide, and a large carboxyl-terminal fragment. Glucagon consists of 29 amino acids in a single-chain polypep tide with a molecular weight of 348 5. In healthy humans, the average fasting plasma immunoreactive glucagon level is 75 pg/mL (25 pmoi! Only 30% to 40% of this is actually pancreatic glu cagon, the remainder being a heterogeneous composite of higher molecular-weight molecules with glucagon immunoreactivity such as proglucagon, glicentin, and oxyntomodulin. Circulating glucagon has a half-life of 3 to 6 minutes due to removal by the liver and kidney.

References

• Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997;10(1):86-124.
• Feng DL, Edwards WD, Oh JK, et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 2007;116:2420.
• Kilickap S, Barista I, Akgul E, et al. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol 2005;16:798-804.
• Dominguez-Cherit G, Posadas-Calleja, Juan G, Borunda D. Chronic Obstructive Pulmonary Disease. In: Critical Care Medicine Principles of Diagnosis and Management in the Adult. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2008:811-826.
• Gitzelmann R. Enzymes of fructose and galactose metabolism: galactose-1-phosphate. In: Curtius H-C, Roth M (eds). Clinical Biochemistry: Principles and Methods. Berlin: Gruyter; 1974, 1236.
• Monahan KD. Effect of aging on baroreflex function in humans. Am J Physiol Regul Integr Comp Physiol 2007;293:3-12.
• van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719-724.
• Loftus CM, editor. Carotid endarterectomy: principles and technique. New York: Informa Healthcare; 2007.